Raising capital at a premium - probability of that happening is just above zero if not less.
This comment demonstrates just how clueless you really are when it comes to Mesoblast
Just look at the last CHF partnership deal that commanded a 45% premium and that was prior to the amazing results of the DREAM-HF phase 3 trial let alone an FDA Accelerated Approval pathway that is now on offer
https://www.fiercebiotech.com/biotech/cephalon-strikes-record-2b-stem-cell-pact-mesoblast
Cephalon strikes record $2B stem cell pact with Mesoblast
Raising capital at a premium - probability of that happening is...
-
- There are more pages in this discussion • 1,651 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |